List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1108 studies with search of: "Anemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab (Rituxan)
2 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath® (Registered Trademark));   Drug: Sirolimus (Rapamune® (Registered Trademark))
3 Completed Study of Deferasirox in Iron Overload From Beta-Thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Conditions: Beta-Thalassemia;   Myelodysplastic Syndromes;   Fanconi Syndrome;   Anemia, Diamond-Blackfan;   Anemia, Aplastic
Intervention: Drug: Deferasirox
4 Completed Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
Conditions: Anemia, Aplastic;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Kostmann Syndrome
Intervention: Procedure: Allogeneic stem cell transplant
5 Recruiting A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Conditions: Aplastic Anemia;   Pure Red Cell Aplasia;   Diamond Blackfan Anemia
Interventions: Drug: Daclizumab;   Drug: Daclizumab (Zenapax)
6 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath® (Registered Trademark))
7 Completed Medical Treatment for Diamond Blackfan Anemia
Conditions: Fanconi's Anemia;   Hematologic Disease
Interventions: Drug: Antithymocyte globulin;   Drug: Cyclosporine
8 Recruiting Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
Conditions: Fanconi Anemia;   Leukemia;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: umbilical cord blood transplantation
9 Completed Heart Disease in Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Pulmonary Hypertension
Intervention:
10 Active, not recruiting L-Glutamine Therapy for Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Thalassemia
Interventions: Drug: L-Glutamine;   Drug: Placebo
11 Completed Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Conditions: Cancer-Related Problem/Condition;   Congenital Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Fanconi Anemia;   Leukemia;   Severe Congenital Neutropenia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
12 Active, not recruiting Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders;   Diamond-Blackfan Anemia;   Fanconi Anemia;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: melphalan;   Drug: methylprednisolone;   Drug: mycophenolate mofetil;   Procedure: radiation therapy;   Procedure: umbilical cord blood transplantation
13 Completed A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: ICA-17043
14 Active, not recruiting L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
Conditions: Sickle Cell Anemia;   Thalassemia
Intervention: Drug: L-glutamine
15 Active, not recruiting Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Behavioral: Blood smear education;   Other: standard education
16 Recruiting Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
Condition: Fanconi Anemia
Intervention: Drug: Oxandrolone
17 Recruiting Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
Conditions: Sickle Cell Anemia;   Priapism;   Pulmonary Hypertension
Interventions: Drug: tadalafil;   Drug: placebo
18 Active, not recruiting Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
19 Completed Hydroxyurea in Young Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: hydroxyurea
20 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services